Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

magnesium

AMCAL MAG-A

magnesium (AMCAL MAG-A) is an FDA-listed pharmaceutical active ingredient. Associated with Blackmores Limited.

TGA: approved NMPA: clinical trials
Patents linked 20
Pipeline programs 26
News articles 0
Drug details — magnesium
Class
—
Route
—
Patents
20
Programs
26
Data quality
0.81
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

magnesium (AMCAL MAG-A) is an FDA-listed pharmaceutical active ingredient. Associated with Blackmores Limited.

Key facts

INN magnesium
Brand AMCAL MAG-A
Originator Blackmores Limited

Approval history

Authority Status Date
TGA approved —
NMPA clinical trials —

Pipeline programs

Browse pipeline Sponsor programs
  1. CADET-PAD Phase 3 · COLLEGIUM PHARMACEUTICAL · Ischemia of the lower limbs in the course of obstructive art
  2. D9612C09998 Phase 3 · AstraZeneca · Erosive Esophagitis
  3. MEDOPP545 Phase 3 · Stemline Therapeutics (United · patients with estrogen receptor-positive/human epidermal gro
  4. METFORMIN for PASC: post-acute sequelae of SARS-CoV-2 infection Phase 3 · Disc Medicine · PASC: post-acute sequelae of SARS-CoV-2 infection
  5. MK-0616-013 Phase 3 · MSD Merck Sharp · Hypercholesterolemia
  6. Magnesium Pantoprazole Phase 3 · Takeda · GERD
  7. Magnesium Pantoprazole 20 mg Phase 3 · Takeda · Gastric pH Control
  8. NW-3509/023/III/2024 Phase 3 · Anaxis Pharma · treatment-resistant schizophrenia (TRS)

Related patents

Browse patents Blackmores Limited patent hub

  1. US 12138233

    Methods of treating idiopathic hypersomnia

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11986446

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11691011

    Pain-relieving apparatus

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11554102

    Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11426373

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11253494

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10897915

    Method for making coffee products containing cannabis ingredients

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10864181

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10675258

    Method of using gamma-hydroxybutyrate compositions for the treatment of disorders

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10405560

    Method for making coffee products containing cannabis ingredients

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10251909

    Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10213400

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10195168

    Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9900622

    Multiple sign bit hiding within a transform unit

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9486426

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9132107

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9050302

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9008184

    Multiple sign bit hiding within a transform unit

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8901173

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8772306

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is magnesium?

magnesium (AMCAL MAG-A) is an FDA-listed pharmaceutical active ingredient. Associated with Blackmores Limited.

What is the brand name for magnesium?

AMCAL MAG-A is a marketed brand name for magnesium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.